Related Experiment Video
Updated: Jun 28, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Oncology: What You May Have Missed in 2023
Courtney H Coschi1, Lorin Dodbiba1, DuPont Guerry2
1Division of Medical Oncology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (C.H.C., L.D.).
Abstract:
Advances in oncology treatment methods have improved outcomes and quality of life for patients with cancer. However, care of these patients can be complex, and the contribution of physicians from different specialties is crucial. This article highlights important publications from 2023 on topics across a wide spectrum relating to the management of oncology patients. The literature was screened for significant new evidence that is relevant to internal medicine specialists and subspecialists whose focus is not oncology. Two articles address the importance of social interventions targeting end-of-life care for low-income and minority patients and the well-being of caregivers. Two additional articles address screening considerations in patients at risk for colorectal and lung cancer. Two more articles address safe use of hormone-related therapies to treat symptoms of menopause and prevent disease recurrence or progression in patients diagnosed with noninvasive breast neoplasia. Finally, several articles were included on topics related to COVID-19 vaccination in patients with cancer, use of cannabinoids for cancer pain control, chronic autoimmune adverse effects related to use of immune checkpoint inhibitors, and the incidence of second primary neoplasms.
Insights
This review covers 2023 oncology advances for non-oncologist physicians, focusing on social interventions, cancer screenings, hormone therapies, and COVID-19 vaccination in cancer patients.
Area of Science:
- Oncology
- Internal Medicine
- Public Health
Background:
- Cancer treatment advances improve patient outcomes and quality of life.
- Complex cancer care necessitates multidisciplinary physician collaboration.
- Evidence review targets non-oncologist specialists managing cancer patients.
Purpose of the Study:
- Highlight significant 2023 publications relevant to oncology patient management.
- Provide crucial updates for internal medicine specialists and subspecialists.
- Synthesize new evidence across diverse oncology-related topics.
Main Methods:
- Literature screening of 2023 publications.
- Focus on evidence relevant to non-oncology specialists.
- Categorization of articles by topic: social interventions, screening, therapies, and COVID-19.
Main Results:
- Key findings on social interventions for end-of-life care and caregiver well-being.
- Updated screening guidelines for colorectal and lung cancer risk.
- Evidence on safe hormone-related therapies for noninvasive breast neoplasia.
- Insights into COVID-19 vaccination, cannabinoid use for pain, immune checkpoint inhibitor side effects, and second primary neoplasms.
Conclusions:
- Non-oncologist physicians require updated knowledge on diverse oncology topics.
- Social determinants and targeted therapies are critical in cancer care.
- Ongoing research addresses survivorship, adverse effects, and emerging challenges in oncology.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

